Matthew Cooper
2021
In 2021, Matthew Cooper earned a total compensation of $1.5M as Former Chief Scientific Officer at BIORA THERAPEUTICS.
Compensation breakdown
| Non-Equity Incentive Plan | $62,622 |
|---|---|
| Option Awards | $628,218 |
| Salary | $527,252 |
| Stock Awards | $274,369 |
| Other | $12,681 |
| Total | $1,505,142 |
Cooper received $628.2K in option awards, accounting for 42% of the total pay in 2021.
Cooper also received $62.6K in non-equity incentive plan, $527.3K in salary, $274.4K in stock awards and $12.7K in other compensation.
Rankings
In 2021, Matthew Cooper's compensation ranked 7,253rd out of 12,415 executives tracked by ExecPay. In other words, Cooper earned more than 41.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,253 out of 12,415 | 42nd |
Division Manufacturing | 3,187 out of 5,505 | 42nd |
Major group Chemicals And Allied Products | 1,413 out of 2,375 | 41st |
Industry group Drugs | 1,257 out of 2,096 | 40th |
Industry Pharmaceutical Preparations | 924 out of 1,546 | 40th |
Source: SEC filing on April 28, 2022.
Cooper's colleagues
We found six more compensation records of executives who worked with Matthew Cooper at BIORA THERAPEUTICS in 2021.
2021
Adi Mohanty
BIORA THERAPEUTICS
Chief Executive Officer
2021
Harry Stylli
BIORA THERAPEUTICS
Chief Executive Officer
2021
Clarke Neumann
BIORA THERAPEUTICS
General Counsel
2021
Eric d'Esparbes
BIORA THERAPEUTICS
Chief Financial Officer
2021
Sami Shihabi
BIORA THERAPEUTICS
Former Chief Commercial Officer
2021
Hutan Hashemi
BIORA THERAPEUTICS